NS5B polymerase — Drug Target

All drugs that target NS5B polymerase — marketed and clinical-stage. Includes 3 drug classes acting on this target.

Drug classes

Protease inhibitor · Antiviral · NS5B polymerase inhibitor

Phase 3 pipeline (2)

• TVR · Janssen R&D Ireland · Protease inhibitor · Infectious diseases
  TVR is a protease inhibitor that works by blocking the replication of the hepatitis C virus.
• CITUS Dry Syrup · SamA Pharmaceutical Co., Ltd · Antiviral · Infectious Diseases
  CITUS Dry Syrup is a medication that works by inhibiting the action of a specific enzyme.

Phase 2 pipeline (1)

• ANA598 · Hoffmann-La Roche · NS5B polymerase inhibitor · Infectious Diseases
  ANA598 is a non-nucleoside inhibitor of the NS5B polymerase of the hepatitis C virus.